Valneva SE (VALN)
USD 3.71
(0.59%)
USD 3.71
(0.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 341.14 Million EUR | -15.04% |
| 2022 | 401.54 Million EUR | -37.92% |
| 2021 | 646.77 Million EUR | 73.98% |
| 2020 | 371.74 Million EUR | 186.9% |
| 2019 | 129.57 Million EUR | 49.41% |
| 2018 | 86.72 Million EUR | -10.3% |
| 2017 | 96.67 Million EUR | -9.51% |
| 2016 | 106.83 Million EUR | -18.36% |
| 2015 | 130.85 Million EUR | 26.95% |
| 2014 | 103.07 Million EUR | -6.54% |
| 2013 | 110.28 Million EUR | 301.41% |
| 2012 | 27.47 Million EUR | -15.83% |
| 2011 | 32.63 Million EUR | -7.31% |
| 2010 | 35.21 Million EUR | 50.31% |
| 2009 | 23.42 Million EUR | 67.7% |
| 2008 | 13.96 Million EUR | 32.1% |
| 2007 | 10.57 Million EUR | 3.03% |
| 2006 | 10.26 Million EUR | 4.48% |
| 2005 | 9.82 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 300.29 Million EUR | -4.24% |
| 2024 Q1 | 313.6 Million EUR | -8.07% |
| 2023 Q4 | 341.14 Million EUR | -6.03% |
| 2023 Q1 | 385.21 Million USD | -4.07% |
| 2023 FY | 341.14 Million EUR | -15.04% |
| 2023 Q2 | 351.86 Million EUR | -8.66% |
| 2023 Q3 | 363.01 Million EUR | 3.17% |
| 2022 Q2 | 631.85 Million EUR | 0.4% |
| 2022 Q3 | 533.1 Million EUR | -15.63% |
| 2022 Q4 | 401.54 Million EUR | -24.68% |
| 2022 FY | 401.54 Million EUR | -37.92% |
| 2022 Q1 | 629.3 Million EUR | -2.7% |
| 2021 Q4 | 646.77 Million EUR | 0.0% |
| 2021 FY | 646.77 Million EUR | 73.98% |
| 2021 Q2 | 668.03 Million EUR | 28.04% |
| 2021 Q1 | 521.75 Million EUR | 40.35% |
| 2020 Q4 | 371.74 Million EUR | -0.46% |
| 2020 FY | 371.74 Million EUR | 186.9% |
| 2020 Q1 | 143.41 Million EUR | 10.69% |
| 2020 Q2 | 278.29 Million EUR | 94.04% |
| 2020 Q3 | 373.45 Million EUR | 34.2% |
| 2019 Q2 | 117.41 Million EUR | 12.3% |
| 2019 FY | 129.57 Million EUR | 49.41% |
| 2019 Q1 | 104.55 Million EUR | 20.56% |
| 2019 Q4 | 129.57 Million EUR | 8.86% |
| 2019 Q3 | 119.02 Million EUR | 1.36% |
| 2018 Q4 | 86.72 Million EUR | 1.3% |
| 2018 Q3 | 85.61 Million EUR | -4.38% |
| 2018 Q2 | 89.53 Million EUR | -2.45% |
| 2018 Q1 | 91.78 Million EUR | -5.06% |
| 2018 FY | 86.72 Million EUR | -10.3% |
| 2017 Q3 | 95.52 Million EUR | -4.54% |
| 2017 Q4 | 96.67 Million EUR | 1.21% |
| 2017 FY | 96.67 Million EUR | -9.51% |
| 2017 Q2 | 100.05 Million EUR | 0.96% |
| 2017 Q1 | 99.1 Million EUR | -7.23% |
| 2016 Q2 | 105.51 Million EUR | -1.92% |
| 2016 FY | 106.83 Million EUR | -18.36% |
| 2016 Q4 | 106.83 Million EUR | 1.37% |
| 2016 Q3 | 105.38 Million EUR | -0.13% |
| 2016 Q1 | 107.58 Million EUR | -17.78% |
| 2015 Q2 | 132.11 Million EUR | -0.06% |
| 2015 FY | 130.85 Million EUR | 26.95% |
| 2015 Q3 | 129.1 Million EUR | -2.28% |
| 2015 Q4 | 130.85 Million EUR | 1.35% |
| 2015 Q1 | 132.19 Million EUR | 28.25% |
| 2014 Q2 | 102.47 Million EUR | -1.53% |
| 2014 FY | 103.07 Million EUR | -6.54% |
| 2014 Q4 | 103.07 Million EUR | -0.4% |
| 2014 Q3 | 103.48 Million EUR | 0.98% |
| 2014 Q1 | 104.07 Million EUR | -5.63% |
| 2013 Q1 | - EUR | -100.0% |
| 2013 Q2 | 124.06 Million EUR | 0.0% |
| 2013 Q3 | 90.94 Million EUR | -26.69% |
| 2013 Q4 | 110.28 Million EUR | 21.25% |
| 2013 FY | 110.28 Million EUR | 301.41% |
| 2012 Q2 | 27.22 Million EUR | 0.0% |
| 2012 Q4 | 27.47 Million EUR | 0.0% |
| 2012 FY | 27.47 Million EUR | -15.83% |
| 2011 Q4 | 32.63 Million EUR | 0.0% |
| 2011 Q2 | 37.62 Million EUR | 0.0% |
| 2011 FY | 32.63 Million EUR | -7.31% |
| 2010 Q2 | 38.03 Million EUR | 0.0% |
| 2010 Q4 | 35.21 Million EUR | 0.0% |
| 2010 FY | 35.21 Million EUR | 50.31% |
| 2009 FY | 23.42 Million EUR | 67.7% |
| 2009 Q4 | 23.42 Million EUR | 0.0% |
| 2008 FY | 13.96 Million EUR | 32.1% |
| 2007 FY | 10.57 Million EUR | 3.03% |
| 2006 FY | 10.26 Million EUR | 4.48% |
| 2005 FY | 9.82 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -11112.85% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 3.319% |
| IO Biotech, Inc. | 17.55 Million USD | -1843.176% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3711.665% |
| Organovo Holdings, Inc. | 2.74 Million USD | -12314.265% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -6604.048% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -84360.818% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -597.18% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1152.916% |
| Savara Inc. | 37.19 Million USD | -817.251% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1799.254% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -362.462% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -869.79% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2990.16% |
| Soligenix, Inc. | 7.27 Million USD | -4589.326% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2057.951% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -353.806% |
| Century Therapeutics, Inc. | 175.94 Million USD | -93.897% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -627.401% |
| Precision BioSciences, Inc. | 140.92 Million USD | -142.083% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 14.126% |
| Kura Oncology, Inc. | 51.66 Million USD | -560.338% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -42038.132% |
| Dyadic International, Inc. | 2.34 Million USD | -14474.749% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -181.282% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1108.616% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -35.054% |
| Autolus Therapeutics plc | 263.9 Million USD | -29.267% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1997.67% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -283.907% |
| GRI Bio, Inc. | 2.69 Million USD | -12549.017% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -997.244% |
| IGM Biosciences, Inc. | 220.17 Million USD | -54.941% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -33.011% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1180.483% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -10299.888% |
| Opthea Limited | 264.6 Million USD | -28.928% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -254.771% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -28.862% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -784.297% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -160.999% |
| Surrozen, Inc. | 8.14 Million USD | -4088.386% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -108593.74% |
| Cingulate Inc. | 10.36 Million USD | -3192.621% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -506.695% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 31.014% |
| Acelyrin, Inc. | 86.35 Million USD | -295.057% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -169.2% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3054.771% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -126.089% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -125.16% |
| ADMA Biologics, Inc. | 193.97 Million USD | -75.869% |
| PureTech Health plc | 125.58 Million USD | -171.648% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5009.241% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3128.085% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1140.028% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -88.698% |
| Synaptogenix, Inc. | 5.52 Million USD | -6069.562% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5031.528% |
| ChromaDex Corporation | 26.5 Million USD | -1186.947% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -9567.628% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -19311.936% |
| Exelixis, Inc. | 678.44 Million USD | 49.717% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -25.288% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1330.853% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -107.956% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 42.589% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -313.844% |
| Seer, Inc. | 39.36 Million USD | -766.618% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -776.369% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -575.105% |
| Gritstone bio, Inc. | 125.91 Million USD | -170.923% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2224.503% |
| Avid Bioservices, Inc. | 275.66 Million USD | -23.752% |
| Insmed Incorporated | 1.66 Billion USD | 79.471% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1966.037% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2392.103% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -147.565% |
| MediWound Ltd. | 27.18 Million USD | -1154.806% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -161.995% |
| Fortress Biotech, Inc. | 165.93 Million USD | -105.584% |
| OmniAb, Inc. | 87.4 Million USD | -290.325% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 15.445% |
| Zai Lab Limited | 240.17 Million USD | -42.039% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 45.855% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -392.726% |
| Veracyte, Inc. | 93.71 Million USD | -264.007% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -593.721% |
| FibroGen, Inc. | 585.72 Million USD | 41.757% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1487.381% |
| ContextLogic Inc. | 206 Million USD | -65.604% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -8154.15% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -52136.493% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -377.258% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 95.544% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -50.395% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4061.308% |
| ImmuCell Corporation | 18.81 Million USD | -1713.147% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 86.971% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1083.624% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2224.503% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 6.048% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 71.936% |
| Theravance Biopharma, Inc. | 169 Million USD | -101.856% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 31.829% |
| Vaxxinity, Inc. | 30.94 Million USD | -1002.456% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 64.92% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -5556.408% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -91755.011% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -10994.662% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -567.562% |
| Senti Biosciences, Inc. | 52.57 Million USD | -548.921% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -12983.961% |
| Apollomics, Inc. | 14.15 Million USD | -2310.401% |
| 89bio, Inc. | 59.96 Million USD | -468.924% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 28.689% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -9567.184% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1197.421% |
| Ardelyx, Inc. | 130.76 Million USD | -160.887% |
| Pluri Inc. | 34.11 Million USD | -900.07% |
| Prothena Corporation plc | 135.01 Million USD | -152.667% |
| Pulmatrix, Inc. | 15.96 Million USD | -2037.092% |
| Celularity Inc. | 102.92 Million USD | -231.436% |
| MeiraGTx Holdings plc | 319.99 Million USD | -6.61% |
| Omeros Corporation | 403.25 Million USD | 15.402% |
| Ainos, Inc. | 7.39 Million USD | -4513.656% |
| Humacyte, Inc. | 114.67 Million USD | -197.482% |
| Mesoblast Limited | 188.79 Million USD | -80.693% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -6897.826% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -344.545% |
| Blueprint Medicines Corporation | 918.64 Million USD | 62.864% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1854.756% |
| Summit Therapeutics Inc. | 125.25 Million USD | -172.355% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -17340.9% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -297.525% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -36.018% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -571.728% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 71.821% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -973.354% |
| Nutriband Inc. | 1.07 Million USD | -31519.056% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3108.351% |
| Roivant Sciences Ltd. | 773.95 Million USD | 55.922% |
| Evogene Ltd. | 17.99 Million USD | -1796.298% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -373.949% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -48290.387% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 81.94% |
| BioLineRx Ltd. | 50.7 Million USD | -572.841% |
| Atai Life Sciences N.V. | 49.16 Million USD | -593.918% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -3541.977% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -100.546% |
| MediciNova, Inc. | 3.89 Million USD | -8666.269% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1766.317% |
| MiMedx Group, Inc. | 96.33 Million USD | -254.141% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 87.466% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -993.375% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -481.324% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -12449.413% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1690.97% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -964.014% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -362.317% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -289.955% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -910.198% |
| Allakos Inc. | 74.79 Million USD | -356.118% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1416.128% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -197.133% |
| BioAtla, Inc. | 48.98 Million USD | -596.411% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -161.205% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2299.887% |
| Precigen, Inc. | 41.64 Million USD | -719.191% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3886.634% |
| XOMA Corporation | 145.58 Million USD | -134.334% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -913.349% |
| Incyte Corporation | 1.59 Billion USD | 78.575% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -396.145% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -451.808% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5063.154% |
| CRISPR Therapeutics AG | 346.76 Million USD | 1.622% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -658.688% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -11786.551% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4081.702% |
| UroGen Pharma Ltd. | 243.52 Million USD | -40.087% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -6.247% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -12253.316% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -4916.824% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -396.015% |
| Chimerix, Inc. | 19.74 Million USD | -1627.749% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -629.892% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -11326.026% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -38.936% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -7678.722% |
| Portage Biotech Inc. | 4.45 Million USD | -7566.157% |
| OncoCyte Corporation | 49.29 Million USD | -592.004% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -8146.557% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -41157.022% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -42677.535% |
| Purple Biotech Ltd. | 10 Million USD | -3309.735% |
| NextCure, Inc. | 14.99 Million USD | -2174.748% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2653.822% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -20911.372% |
| Generation Bio Co. | 171.63 Million USD | -98.767% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1157.952% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 1.852% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3025.747% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3094.171% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3154.57% |
| Novavax, Inc. | 2.57 Billion USD | 86.738% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -95045.978% |
| Curis, Inc. | 57.61 Million USD | -492.141% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1195.655% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -23524.931% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -4333.883% |
| Bicycle Therapeutics plc | 224.41 Million USD | -52.017% |
| BeiGene, Ltd. | 2.23 Billion USD | 84.728% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1502.382% |
| Alector, Inc. | 487.66 Million USD | 30.046% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1503.572% |
| Erasca, Inc. | 78.61 Million USD | -333.965% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1751.528% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1067.222% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -789.021% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -6518.976% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -51963.023% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2761.466% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 81.951% |
| Histogen Inc. | 5.69 Million USD | -5888.134% |
| Fortress Biotech, Inc. | 165.93 Million USD | -105.584% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -166.955% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -258.808% |
| Galecto, Inc. | 5.89 Million USD | -5686.024% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -12937.319% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 29.892% |
| Molecular Templates, Inc. | 31.17 Million USD | -994.428% |
| PDS Biotechnology Corporation | 33.25 Million USD | -925.715% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -306.017% |
| Amarin Corporation plc | 279.58 Million USD | -22.017% |
| TG Therapeutics, Inc. | 169.08 Million USD | -101.759% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2602.987% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -835.769% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -513.182% |
| Onconetix, Inc. | 23.18 Million USD | -1371.661% |
| MacroGenics, Inc. | 154.2 Million USD | -121.225% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1168.948% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -8339.98% |
| Adagene Inc. | 45.16 Million USD | -655.256% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -29.031% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 54.223% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -196.748% |
| SciSparc Ltd. | 1.59 Million USD | -21288.339% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6030.287% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -299.662% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2853.628% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -715.529% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -35.001% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -270.901% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 91.578% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2718.277% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -33312.733% |
| 2seventy bio, Inc. | 310.12 Million USD | -10.002% |
| Clene Inc. | 38.95 Million USD | -775.829% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -32.753% |
| GeoVax Labs, Inc. | 3.51 Million USD | -9591.919% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -5932.12% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -788.789% |
| Scopus BioPharma Inc. | 7.45 Million USD | -4476.39% |
| Absci Corporation | 58.3 Million USD | -485.113% |
| XBiotech Inc. | 8.39 Million USD | -3962.689% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -545.605% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -541.489% |
| Entera Bio Ltd. | 1.37 Million USD | -24638.506% |
| Trevena, Inc. | 48.26 Million USD | -606.858% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -40.329% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -370.109% |
| INmune Bio, Inc. | 18.86 Million USD | -1708.631% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2700.932% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1479.736% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -12305.236% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -814.791% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -9411.839% |
| Jaguar Health, Inc. | 45.86 Million USD | -643.784% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -583.245% |
| NexImmune, Inc. | 5.08 Million USD | -6609.843% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1272.868% |
| Clearmind Medicine Inc. | 3.61 Million USD | -9349.951% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -8979.921% |
| Kronos Bio, Inc. | 54.2 Million USD | -529.405% |
| Innoviva, Inc. | 568.55 Million USD | 39.998% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 58.55% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 95.2% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -625.175% |
| Verastem, Inc. | 71.18 Million USD | -379.236% |
| ProKidney Corp. | 29.21 Million USD | -1067.662% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1398.893% |
| Imunon, Inc. | 8.53 Million USD | -3899.143% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1599.686% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1404.398% |
| ImmunityBio, Inc. | 1.09 Billion USD | 68.714% |
| Korro Bio, Inc. | 51.75 Million USD | -559.19% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 41.992% |
| Kineta, Inc. | 7.22 Million USD | -4623.678% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -305.998% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -844.138% |
| GT Biopharma, Inc. | 6.63 Million USD | -5043.133% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -802.211% |
| Celularity Inc. | 102.92 Million USD | -231.436% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -254.446% |
| CalciMedica, Inc. | 4.02 Million USD | -8369.315% |
| Cibus, Inc. | 206.11 Million USD | -65.51% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -161.74% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -121.317% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -703.164% |
| Kodiak Sciences Inc. | 213.59 Million USD | -59.718% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -22.805% |
| Annexon, Inc. | 47.11 Million USD | -624.021% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -280.992% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -253.987% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2062.835% |
| Moderna, Inc. | 4.57 Billion USD | 92.538% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1286.426% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 86.896% |
| Vor Biopharma Inc. | 59.1 Million USD | -477.193% |
| Eyenovia, Inc. | 19.78 Million USD | -1624.667% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -10894.006% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -92.643% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -174.0% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -49.99% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4341.401% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -7.548% |
| Immunocore Holdings plc | 228.15 Million USD | -49.521% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -128.253% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -285.731% |
| Alkermes plc | 933.53 Million USD | 63.457% |
| Arcellx, Inc. | 339.75 Million USD | -0.41% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -995.084% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -173.712% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -5933.675% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -3467.332% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -22578.813% |
| Moolec Science SA | 13.94 Million USD | -2346.291% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1011.58% |
| RenovoRx, Inc. | 4.46 Million USD | -7538.692% |
| Geron Corporation | 146.12 Million USD | -133.457% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2037.226% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -451.709% |
| Royalty Pharma plc | 6.29 Billion USD | 94.583% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -757.663% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -115775.356% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -4018.107% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -13766.053% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -80.351% |
| Humacyte, Inc. | 114.67 Million USD | -197.482% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1074.293% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3094.171% |
| Genelux Corporation | 8.42 Million USD | -3951.591% |
| ESSA Pharma Inc. | 3.49 Million USD | -9660.717% |
| aTyr Pharma, Inc. | 31.59 Million USD | -979.672% |
| Notable Labs, Ltd. | 4.42 Million USD | -7605.986% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -10475.574% |
| Mustang Bio, Inc. | 17.61 Million USD | -1836.228% |
| Immunovant, Inc. | 48.95 Million USD | -596.852% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1823.766% |
| Vericel Corporation | 127.7 Million USD | -167.134% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 79.318% |
| Akari Therapeutics, Plc | 4.58 Million USD | -7342.059% |
| Acasti Pharma Inc. | 11.55 Million USD | -2851.839% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1408.971% |
| Vaxcyte, Inc. | 167.44 Million USD | -103.73% |
| Orgenesis Inc. | 35.53 Million USD | -860.023% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1143.372% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -5496.194% |
| GH Research PLC | 6.7 Million USD | -4990.942% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1273.642% |
| PepGen Inc. | 34.63 Million USD | -885.083% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2709.157% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2697.455% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3886.634% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -108593.74% |
| Silo Pharma, Inc. | 1.56 Million USD | -21639.025% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -25443.066% |
| Belite Bio, Inc | 4.21 Million USD | -8001.259% |
| Pharming Group N.V. | 244.07 Million USD | -39.771% |
| XOMA Corporation | 145.58 Million USD | -134.334% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1712.09% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5063.154% |
| Bionomics Limited | 10.15 Million USD | -3258.139% |
| Xencor, Inc. | 283.55 Million USD | -20.308% |
| Replimune Group, Inc. | 113.21 Million USD | -201.327% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -610.391% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2303.269% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -229.512% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -188689.215% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2311.252% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1075.75% |
| GeoVax Labs, Inc. | 3.51 Million USD | -9591.919% |
| MEI Pharma, Inc. | 8.35 Million USD | -3983.112% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1380.017% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -22578.813% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -12175.783% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -4956.232% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -5796.025% |
| scPharmaceuticals Inc. | 57.26 Million USD | -495.77% |
| HilleVax, Inc. | 78.9 Million USD | -332.326% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -361.873% |
| Tharimmune, Inc. | 1.81 Million USD | -18695.336% |
| Genprex, Inc. | 3.25 Million USD | -10383.165% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1862.515% |
| Immunic, Inc. | 25.36 Million USD | -1244.781% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -6415.355% |
| Aptorum Group Limited | 5.25 Million USD | -6389.652% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1371.463% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1862.515% |
| OKYO Pharma Limited | 7.42 Million USD | -4497.104% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -770.27% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1538.619% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5058.021% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 44.772% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -26157.176% |
| bluebird bio, Inc. | 424.62 Million USD | 19.66% |
| DBV Technologies S.A. | 42.8 Million USD | -697.065% |
| Compugen Ltd. | 55.77 Million USD | -511.643% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -51963.023% |
| Peak Bio, Inc. | 20.75 Million USD | -1543.801% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -4776.969% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -20500.483% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -3498.945% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1155.637% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -208.831% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1898.5% |
| Benitec Biopharma Inc. | 4.96 Million USD | -6775.131% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -116.129% |
| Adicet Bio, Inc. | 37.12 Million USD | -819.03% |
| Prime Medicine, Inc. | 60.78 Million USD | -461.277% |
| Aditxt, Inc. | 28.53 Million USD | -1095.673% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -45.036% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -188689.215% |
| Quantum-Si incorporated | 26.63 Million USD | -1181.003% |
| GlycoMimetics, Inc. | 6.9 Million USD | -4842.63% |
| PolyPid Ltd. | 17.46 Million USD | -1852.965% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -203.512% |
| Invivyd, Inc. | 51.71 Million USD | -559.687% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -5144.133% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -133.87% |
| CorMedix Inc. | 11.91 Million USD | -2762.54% |
| Instil Bio, Inc. | 99.8 Million USD | -241.824% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -79.301% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -72.015% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -609.077% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -351.87% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1388.867% |
| AbCellera Biologics Inc. | 335.77 Million USD | -1.599% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -111.984% |
| Surrozen, Inc. | 8.14 Million USD | -4088.386% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -846.098% |
| Verona Pharma plc | 58.84 Million USD | -479.773% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2494.251% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 7.763% |
| Evaxion Biotech A/S | 17.61 Million USD | -1836.395% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -122.699% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2195.875% |
| AlloVir, Inc. | 45.01 Million USD | -657.845% |
| BioVie Inc. | 9.7 Million USD | -3416.176% |
| Codexis, Inc. | 49.94 Million USD | -583.026% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2272.515% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -84360.818% |
| Agenus Inc. | 462.29 Million USD | 26.206% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -98726.747% |
| Lantern Pharma Inc. | 2.73 Million USD | -12351.956% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -604.814% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1195.205% |
| Immix Biopharma, Inc. | 3.72 Million USD | -9066.144% |
| Celcuity Inc. | 51.45 Million USD | -563.058% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2767.238% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -690.564% |
| IN8bio, Inc. | 8.77 Million USD | -3789.01% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -28423.746% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -4875.846% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -150.254% |
| Liquidia Corporation | 73.13 Million USD | -366.439% |
| Quantum-Si incorporated | 26.63 Million USD | -1181.003% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -12449.413% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -825.086% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5035.391% |
| United Therapeutics Corporation | 1.18 Billion USD | 71.143% |
| Solid Biosciences Inc. | 38.45 Million USD | -787.056% |
| Immuneering Corporation | 12 Million USD | -2740.889% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1388.867% |
| uniQure N.V. | 624.01 Million USD | 45.331% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1315.594% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -14457.005% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -100.456% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3390.321% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1189.136% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -24931.809% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1295.557% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -4784.651% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -13950.412% |
| Zura Bio Limited | 21.29 Million USD | -1502.217% |
| Forte Biosciences, Inc. | 3.66 Million USD | -9205.619% |
| Elevation Oncology, Inc. | 34.28 Million USD | -895.111% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4341.401% |
| Immunome, Inc. | 28.65 Million USD | -1090.397% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3991.928% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2257.106% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -513.62% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -6899.261% |
| Altimmune, Inc. | 16.54 Million USD | -1962.415% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -483.601% |
| Rallybio Corporation | 9.43 Million USD | -3515.345% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2578.58% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3138.196% |
| Moolec Science SA | 13.94 Million USD | -2346.291% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -130815.678% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -165503.883% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -6394.27% |
| NeurAxis, Inc. | 1.91 Million USD | -17735.366% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 51.095% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2458.644% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2257.106% |
| 180 Life Sciences Corp. | 5.38 Million USD | -6232.481% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -353.806% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1346.261% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1398.893% |
| Nutriband Inc. | 1.07 Million USD | -31519.056% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2250.934% |
| argenx SE | 444.95 Million USD | 23.33% |
| Neurogene Inc. | 36.54 Million USD | -833.388% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 14.275% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -13852.72% |
| CervoMed Inc. | 2.59 Million USD | -13042.421% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -615.937% |
| Sesen Bio, Inc. | 30.98 Million USD | -1001.033% |
| AnaptysBio, Inc. | 364.28 Million USD | 6.353% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2753.329% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2589.562% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -776.346% |
| Achilles Therapeutics plc | 19.08 Million USD | -1687.311% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -6655.327% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1014.923% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 14.985% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -950.547% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2514.311% |
| Palisade Bio, Inc. | 2.73 Million USD | -12355.057% |
| Beam Therapeutics Inc. | 478.38 Million USD | 28.688% |
| AEON Biopharma, Inc. | 159.88 Million USD | -113.363% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1214.063% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -4387.428% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -74.286% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -77.626% |
| Athira Pharma, Inc. | 30.05 Million USD | -1034.99% |
| Vaccinex, Inc. | 5.94 Million USD | -5641.232% |
| HCW Biologics Inc. | 15.05 Million USD | -2166.445% |
| XOMA Corporation | 145.58 Million USD | -134.334% |
| Nektar Therapeutics | 267.04 Million USD | -27.747% |
| Arvinas, Inc. | 644.6 Million USD | 47.077% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1823.766% |
| Merus N.V. | 102.15 Million USD | -233.961% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -133.101% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -258.646% |
| Rezolute, Inc. | 11.73 Million USD | -2807.312% |
| Clene Inc. | 38.95 Million USD | -775.829% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -11880.979% |
| BeyondSpring Inc. | 48.26 Million USD | -606.756% |
| Synlogic, Inc. | 32.89 Million USD | -937.069% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2234.524% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -20777.846% |
| Peak Bio, Inc. | 20.75 Million USD | -1543.801% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -437.582% |
| Krystal Biotech, Inc. | 39.71 Million USD | -759.002% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 9.425% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -242.621% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -78736.03% |
| MannKind Corporation | 721.36 Million USD | 52.709% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1427.396% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -16253.979% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -232.531% |
| Gossamer Bio, Inc. | 249.14 Million USD | -36.925% |
| CohBar, Inc. | 1.03 Million USD | -32904.205% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3091.543% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1690.97% |
| Legend Biotech Corporation | 589.93 Million USD | 42.172% |
| Mural Oncology plc | 37.92 Million USD | -799.452% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -157.203% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -14762.512% |
| Disc Medicine, Inc. | 22.87 Million USD | -1391.34% |
| Champions Oncology, Inc. | 28.03 Million USD | -1116.85% |
| REGENXBIO Inc. | 262.22 Million USD | -30.094% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -10055.054% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2621.749% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2439.856% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1508.79% |
| Vaxart, Inc. | 34.02 Million USD | -902.627% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1573.155% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1095.659% |
| Cellectis S.A. | 249.57 Million USD | -36.69% |
| Longeveron Inc. | 5.33 Million USD | -6292.055% |
| Repare Therapeutics Inc. | 41.81 Million USD | -715.763% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 85.817% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -465.107% |
| Revolution Medicines, Inc. | 262.39 Million USD | -30.011% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -16090.982% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3854.834% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2790.806% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2329.281% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -15759.786% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 93.376% |
| Denali Therapeutics Inc. | 122.96 Million USD | -177.436% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6030.287% |
| Veru Inc. | 32.81 Million USD | -939.67% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -4866.429% |
| Cingulate Inc. | 10.36 Million USD | -3192.621% |
| Passage Bio, Inc. | 39.26 Million USD | -768.891% |
| Context Therapeutics Inc. | 4.19 Million USD | -8038.53% |
| Exicure, Inc. | 8.54 Million USD | -3890.455% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1056.107% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3153.328% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -30.011% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1447.77% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -109.309% |
| Nuvalent, Inc. | 31.82 Million USD | -972.005% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -5262.528% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -441.309% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1795.244% |
| OmniAb, Inc. | 87.4 Million USD | -290.325% |
| Anew Medical, Inc. | 8.24 Million USD | -4039.193% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -790.969% |
| Lipocine Inc. | 2.63 Million USD | -12863.225% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1198.508% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -748.364% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1180.483% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -295.97% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -6216.312% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -312.274% |
| Ocugen, Inc. | 23.98 Million USD | -1322.441% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -635.113% |
| Q32 Bio Inc. | 233.12 Million USD | -46.333% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -3662.894% |
| Alumis Inc. Common Stock | 53.5 Million USD | -537.628% |
| Equillium, Inc. | 27.95 Million USD | -1120.245% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -65.129% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -5962.988% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -5462.462% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -116.839% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -391.328% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3320.264% |
| Dominari Holdings Inc. | 4.63 Million USD | -7260.173% |
| Edesa Biotech, Inc. | 1.84 Million USD | -18423.955% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1053.8% |
| Bio-Techne Corporation | 744.34 Million USD | 54.168% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -170.537% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 0.962% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -740.774% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1078.105% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -269.363% |
| Nkarta, Inc. | 105.6 Million USD | -223.053% |
| BioCardia, Inc. | 4.59 Million USD | -7332.331% |
| Iterum Therapeutics plc | 32.66 Million USD | -944.468% |